{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:21:29Z","timestamp":1740147689280,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11739-024-03641-4","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T15:25:59Z","timestamp":1721748359000},"page":"1593-1604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medical occurrence and safety of SARS-CoV-2 vaccination outside of the hospital setting"],"prefix":"10.1007","volume":"19","author":[{"given":"Fiorenza","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Sodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Madotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Carlesso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Florio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosa","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Laquintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bisesti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Piatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Letzgus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navpreet","family":"Tiwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Jachetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mancarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Cereda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia Rosanna","family":"Borriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Chiappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Sottocorno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"3641_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1620\/tjem.250.271","volume":"250","author":"S Baloch","year":"2020","unstructured":"Baloch S, Baloch MA, Zheng T, Pei X (2020) The Coronavirus disease 2019 (COVID-19) pandemic. Tohoku J Exp Med 250:271\u2013278. https:\/\/doi.org\/10.1620\/tjem.250.271","journal-title":"Tohoku J Exp Med"},{"key":"3641_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33575","author":"YN Suryawanshi","year":"2023","unstructured":"Suryawanshi YN, Biswas DA (2023) Herd immunity to fight against COVID-19: a narrative review. Cureus. https:\/\/doi.org\/10.7759\/cureus.33575","journal-title":"Cureus"},{"key":"3641_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.38871","volume":"5","author":"G Grasselli","year":"2022","unstructured":"Grasselli G, Zanella A, Carlesso E, Florio G, Canakoglu A, Bellani G, Bottino N, Cabrini L, Castelli GP, Catena E, Cecconi M, Cereda D, Chiumello D, Forastieri A, Foti G, Gemma M, Giudici R, Grazioli L, Lombardo A, Lorini FL, Madotto F, Mantovani A, Mistraletti G, Mojoli F, Mongodi S, Monti G, Muttini S, Piva S, Protti A, Rasulo F, Scandroglio AM, Severgnini P, Storti E, Fumagalli R, Pesenti A, Keim R, Vagginelli F, Sala A, Merli G, Ruggeri P, Villani G, Riccio M, Zoia E, Castelli A, Colombo R, Rech R, Gnesin P, Coppini D, Petrucci N, Antonini B, Landolfi L, Arnaiz F, Forlini C, Stefanini F, Micucci A, Marelli JA, Torresani F, Panzeri C, Paolini E, Guzzon D, Maderna L, Russo G, Berselli A, Biondo A, Montalto C, Bianciardi L, Della Mura F, Marino G, Zambon M, Subert M, Citerio G, Saini M, Rona R, Pezzi A, Sabbatini G, Paganini S, Porta V, Benigni A, Bonanomi E, Fabretti F, Gritti P, Arachi G, Raimondi M, Casazza A, De Filippi G, Piccoli F, Umbrello M, Coppola S, Pozzi T, Corona A, Bossi E, Greco S, Besozzi A, Covello RD, Della Morte M, Sangalli F, Gasberti D, Maraggia D, Motta A, Agosteo E, Crottogini L, Leoni O, Tirani M, Carbonara M, Crotti S, Fusaris C, Properzi P, Rossi N, Tagliabue P, Tubiolo D, Maggio G, Pagani M, Sciutti F, Bertelli M, Militano CR, Morandi A, Valsecchi R, Albano G, Barbara E, Ballotta A, Costantini E, Greco M, Perazzo P, Ceriani R, Ranucci M, Resta M, Calvi MR, Colombo S, Dell\u2019Acqua A, Marino F, Sebastiano P, Sala G, Belgiorno N, Cosio R, Guatteri L, Viola U, Galletti M, Primerano V, Visetti E, Giacomini M, Alborghetti A, Bertazzoli A, Bertoni M, Mauri T, Prato G, Stocchetti N, Vivona L, Waccher G, Filippini M, Latronico N, Giani M, Pozzi M (2022) Association of COVID-19 vaccinations with intensive care unit admissions and outcome of critically ill patients with COVID-19 pneumonia in Lombardy. Italy JAMA Netw Open 5:e2238871. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.38871","journal-title":"Italy JAMA Netw Open"},{"key":"3641_CR4","unstructured":"Gruppo di Lavoro ISS Bioetica COVID-19 (2020) Etica della ricerca durante la pandemia di COVID-19: studi osservazionali e in particolare epidemiologici. Versione del 29 maggio 2020. Roma: Istituto Superiore di Sanit\u00e0; 2020. (Rapporto ISS COVID-19 n. 47\/2020"},{"key":"3641_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med"},{"key":"3641_CR6","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1016\/j.vaccine.2013.08.087","volume":"31","author":"AE Tozzi","year":"2013","unstructured":"Tozzi AE, Asturias EJ, Balakrishnan MR, Halsey NA, Law B, Zuber PLF (2013) Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use. Vaccine 31:5041\u20135046. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.087","journal-title":"Vaccine"},{"key":"3641_CR7","unstructured":"European Medicines Agency (EMA) (2017) Guidelines on good pharmacovigilance practices (GVP). https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guidelines-good-pharmacovigilance-practices-gvp-introductory-cover-note-last-updated-12-october-2017_en.pdf. Accessed 2 Mar 2024"},{"key":"3641_CR8","unstructured":"World Health Organizzation (WHO) (2019) Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification, 2nd ed., 2019 update"},{"key":"3641_CR9","unstructured":"Medicines & Healthcare products Regulatory Agency (2021) Coronavirus vaccine - weekly summary of Yellow Card reporting (Data included: 09\/12\/2020 to 21\/02\/2021)"},{"key":"3641_CR10","unstructured":"Brighton Collaboration Anaphylaxis Working Group (2021) Anaphylaxis: case definition companion guide. https:\/\/brightoncollaboration.us\/anaphylaxis-case-definition-companion-guide\/. Accessed 2 Mar 2024"},{"key":"3641_CR11","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/vaccines10122157","volume":"10","author":"MA AlHamaidah","year":"2022","unstructured":"AlHamaidah MA, Noureldin N, Yehia A, Alani I, Al-Qussain A, Abdou O, Ashames A, Kharaba Z (2022) Efficacy and short-term safety of COVID-19 vaccines: a cross-sectional study on vaccinated people in the UAE. Vaccines (Basel) 10:2157. https:\/\/doi.org\/10.3390\/vaccines10122157","journal-title":"Vaccines (Basel)"},{"key":"3641_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/IJGM.S310497","volume":"14","author":"NA El-Shitany","year":"2021","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid BG, Almukadi HS, Alghamdi BS, Alahmadi AA, Hassan NA, Sindi N, Alghamdi SA, Almohaimeed HM, Mohammedsaleh ZM, Al-Shaikh TM, Almuhayawi MS, Ali SS, El-Hamamsy M (2021) Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among saudi residents: a retrospective cross-sectional study. Int J Gen Med 14:1389\u20131401. https:\/\/doi.org\/10.2147\/IJGM.S310497","journal-title":"Int J Gen Med"},{"key":"3641_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3349\/ymj.2021.62.12.1162","volume":"62","author":"JH Im","year":"2021","unstructured":"Im JH, Kim E, Lee E, Seo Y, Lee Y, Jang Y, Yu S, Maeng Y, Park S, Park S, Kim J, Lee J-S, Baek JH (2021) Adverse events with the Pfizer-BioNTech COVID-19 vaccine among Korean Healthcare Workers. Yonsei Med J 62:1162. https:\/\/doi.org\/10.3349\/ymj.2021.62.12.1162","journal-title":"Yonsei Med J"},{"key":"3641_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jiac.2021.12.034","volume":"28","author":"H Kitagawa","year":"2022","unstructured":"Kitagawa H, Kaiki Y, Sugiyama A, Nagashima S, Kurisu A, Nomura T, Omori K, Akita T, Shigemoto N, Tanaka J, Ohge H (2022) Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan. J Infect Chemother 28:576\u2013581. https:\/\/doi.org\/10.1016\/j.jiac.2021.12.034","journal-title":"J Infect Chemother"},{"key":"3641_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033236","volume":"102","author":"DY Lee","year":"2023","unstructured":"Lee DY, Kang DY, Kim E, Lee S, Baek JH, Lee J-S, Park MY, Im JH (2023) Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers. Medicine 102:e33236. https:\/\/doi.org\/10.1097\/MD.0000000000033236","journal-title":"Medicine"},{"key":"3641_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, Hu C, Selvachandran S, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Modat M, Joshi AD, Mangino M, Hammers A, Goodman AL, Chan AT, Wolf J, Steves CJ, Valdes AM, Ourselin S, Spector TD (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21:939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3","journal-title":"Lancet Infect Dis"},{"key":"3641_CR17","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2022.12.e35","volume":"12","author":"B\u00d6 \u00d6zt\u00fcrk","year":"2022","unstructured":"\u00d6zt\u00fcrk B\u00d6, Akdemir \u0130, Azap A, \u00c7elik G, Bavbek S, Mungan D (2022) Anaphylaxis is rare due to CoronaVac in a population of healthcare workers. Asia Pac Allergy 12:e35. https:\/\/doi.org\/10.5415\/apallergy.2022.12.e35","journal-title":"Asia Pac Allergy"},{"key":"3641_CR18","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/jcm10071428","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M (2021) Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med 10:1428. https:\/\/doi.org\/10.3390\/jcm10071428","journal-title":"J Clin Med"},{"key":"3641_CR19","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/jcm10122629","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Sa\u011f\u0131ro\u011flu D, \u00dcst\u00fcn B, Pokorn\u00e1 A, Klugarov\u00e1 J, Attia S, Klugar M (2021) Prevalence and risk factors of CoronaVac side effects: an independent cross-sectional study among healthcare workers in Turkey. J Clin Med 10:2629. https:\/\/doi.org\/10.3390\/jcm10122629","journal-title":"J Clin Med"},{"key":"3641_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12879-022-07175-y","volume":"22","author":"R Urakawa","year":"2022","unstructured":"Urakawa R, Isomura ET, Matsunaga K, Kubota K, Ike M (2022) Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study. BMC Infect Dis 22:179. https:\/\/doi.org\/10.1186\/s12879-022-07175-y","journal-title":"BMC Infect Dis"},{"key":"3641_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2021.1967","volume":"325","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro TT, Cole M, Su JR (2021) Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014December 14, 2020\u2013January 18, 2021. JAMA 325:1101. https:\/\/doi.org\/10.1001\/jama.2021.1967","journal-title":"JAMA"},{"key":"3641_CR22","unstructured":"Japanese Ministry of Health L and Welfare (2021) The 57th health science council vaccination\/vaccine subcommittee side reaction study subcommittee, the 4th pharmaceutical affairs\/food sanitation council pharmaceutical affairs subcommittee safety measures study group (jointly held) conference materials [Internet]. https:\/\/www.mhlw.go.jp\/stf\/shingi2\/0000208910_00021.html. Accessed 13 Sep 2023"},{"key":"3641_CR23","unstructured":"Korea Disease Control and Prevention Agency (2021) Korea disease control and prevention agency. Updates on COVID-19 in Republic of Korea (as of 9 May, 2021 from 26 February, 2021). http:\/\/ncov.mohw.go.kr\/en\/tcmBoardList.do?brdId=12&brdGubun=125&dataGubun=&ncvContSeq=&contSeq=&board_id=&gubun=. Accessed 13 Sep 2023"},{"key":"3641_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4168\/aair.2021.13.4.526","volume":"13","author":"M-A Kim","year":"2021","unstructured":"Kim M-A, Lee YW, Kim SR, Kim J-H, Min TK, Park H-S, Shin M, Ye Y-M, Lee S, Lee J, Choi J-H, Jang GC, Chang Y-S (2021) COVID-19 vaccine-associated anaphylaxis and allergic reactions: consensus statements of the KAAACI Urticaria\/Angioedema\/Anaphylaxis Working Group. Allergy Asthma Immunol Res 13:526. https:\/\/doi.org\/10.4168\/aair.2021.13.4.526","journal-title":"Allergy Asthma Immunol Res"},{"key":"3641_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.18176\/jiaci.0667","volume":"31","author":"M Caballero","year":"2021","unstructured":"Caballero M, Quirce S (2021) Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of currently authorized COVID-19 vaccines. J Investig Allergol Clin Immunol 31:92\u201393. https:\/\/doi.org\/10.18176\/jiaci.0667","journal-title":"J Investig Allergol Clin Immunol"},{"key":"3641_CR26","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1111\/all.14794","volume":"76","author":"L Klimek","year":"2021","unstructured":"Klimek L, Novak N, Cabanillas B, Jutel M, Bousquet J, Akdis CA (2021) Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation. Allergy 76:3307\u20133313. https:\/\/doi.org\/10.1111\/all.14794","journal-title":"Allergy"},{"key":"3641_CR27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","volume":"7","author":"CA Stone","year":"2019","unstructured":"Stone CA, Liu Y, Relling MV, Krantz MS, Pratt AL, Abreo A, Hemler JA, Phillips EJ (2019) Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized. J Allergy Clin Immunol Pract 7:1533-1540.e8. https:\/\/doi.org\/10.1016\/j.jaip.2018.12.003","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3641_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2021.102489","volume":"84","author":"S Taylor","year":"2021","unstructured":"Taylor S, Asmundson GJG (2021) Immunization stress-related responses: implications for vaccination hesitancy and vaccination processes during the COVID-19 pandemic. J Anxiety Disord 84:102489. https:\/\/doi.org\/10.1016\/j.janxdis.2021.102489","journal-title":"J Anxiety Disord"},{"key":"3641_CR29","unstructured":"AIFA (2021) Nono rapporto AIFA sulla sorveglianza dei vaccini COVID-19. https:\/\/www.aifa.gov.it\/-\/nono-rapporto-aifa-sulla-sorveglianza-dei-vaccini-covid-19. Accessed 1 Aug 2023"},{"key":"3641_CR30","unstructured":"Agenzia Italiana del Farmaco (AIFA) Vaccini COVID-19. https:\/\/www.aifa.gov.it\/vaccini-covid-19. Accessed 2 Mar 2024"},{"key":"3641_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/life11030249","volume":"11","author":"AG Mathioudakis","year":"2021","unstructured":"Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, Petrakis D, Bakerly ND (2021) Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey. Life 11:249. https:\/\/doi.org\/10.3390\/life11030249","journal-title":"Life"},{"key":"3641_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/biology10080752","volume":"10","author":"M Klugar","year":"2021","unstructured":"Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt H-P, Attia S (2021) Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German Healthcare Workers. Biology (Basel) 10:752. https:\/\/doi.org\/10.3390\/biology10080752","journal-title":"Biology (Basel)"},{"key":"3641_CR33","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"3641_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.937794","author":"EA Yesuf","year":"2022","unstructured":"Yesuf EA, Riad A, Sofi-Mahmudi A, Sudhakar M, Mekonnen A, Endalkachew S, Mama F, Muhidin S, Ayele B, Yahya M, Usman A, Abafita J, Klugar M (2022) Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: a cross-sectional study. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2022.937794","journal-title":"Front Public Health"},{"key":"3641_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/vaccines10020233","volume":"10","author":"MS Green","year":"2022","unstructured":"Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D (2022) Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine. Vaccines (Basel) 10:233. https:\/\/doi.org\/10.3390\/vaccines10020233","journal-title":"Vaccines (Basel)"},{"key":"3641_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.15537\/smj.2021.42.12.20210576","volume":"42","author":"W Ahsan","year":"2021","unstructured":"Ahsan W, Syed NK, Alsraeya AA, Alhazmi HA, Najmi A, Al BM, Javed S, Makeen HA, Meraya AM, Albarraq AA, Alqahtani SS (2021) Post-vaccination survey for monitoring the side effects associated with COVID-19 vaccines among healthcare professionals of Jazan province, Saudi Arabia. Saudi Med J 42:1341\u20131352. https:\/\/doi.org\/10.15537\/smj.2021.42.12.20210576","journal-title":"Saudi Med J"},{"key":"3641_CR37","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","volume":"383","author":"EE Walsh","year":"2020","unstructured":"Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi P-Y, T\u00fcreci \u00d6, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, \u015eahin U, Gruber WC (2020) Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med 383:2439\u20132450. https:\/\/doi.org\/10.1056\/NEJMoa2027906","journal-title":"N Engl J Med"},{"key":"3641_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich J (2018) The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol 19:10\u201319. https:\/\/doi.org\/10.1038\/s41590-017-0006-x","journal-title":"Nat Immunol"},{"key":"3641_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-019-0124-6","volume":"4","author":"T Potluri","year":"2019","unstructured":"Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, vom Steeg L, Deshpande S, Narasimhan H, Klein SL (2019) Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines 4:29. https:\/\/doi.org\/10.1038\/s41541-019-0124-6","journal-title":"NPJ Vaccines"},{"key":"3641_CR40","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1136\/ejhpharm-2021-002933","volume":"30","author":"A Ossato","year":"2023","unstructured":"Ossato A, Tessari R, Trabucchi C, Zuppini T, Realdon N, Marchesini F (2023) Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021. Eur J Hosp Pharm 30:e15\u2013e15. https:\/\/doi.org\/10.1136\/ejhpharm-2021-002933","journal-title":"Eur J Hosp Pharm"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03641-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:19:15Z","timestamp":1726489155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03641-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03641-4","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GG reports consultation fees from Getinge, Draeger, Pfizer, ThermoFisher, MSD and Gilead. The remaining authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local Human Research Ethics Committee Area 2 Milano (n. 0040271 U, June 6th, 2021) and complied with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The type of study design and setting (the pandemic emergency) let omit the informed consent to participate (Gruppo di Lavoro ISS Bioetica COVID-19. (2020) Etica della ricerca durante la pandemia di COVID-19: studi osservazionali e in particolare epidemiologici. Versione del 29 maggio 2020. Roma: Istituto Superiore di Sanit\u00e0; 2020. (Rapporto ISS COVID-19 n. 47\/2020).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}